Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 277 to 282 of 282 entries
Sorted by: Best Match Show Resources per page
Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV.

AIDS (London, England)

Yu W, Jacobson DL, Williams PL, Patel K, Geffner ME, van Dyke RB, Kacanek D, DiMeglio LA, Jao J.
PMID: 34860195
AIDS. 2021 Dec 06; doi: 10.1097/QAD.0000000000003136. Epub 2021 Dec 06.

OBJECTIVE: To compare long-term growth between HIV-exposed uninfected children (CHEU) born to women with perinatally-acquired HIV (CHEU-PHIV) and CHEU born to women with non-perinatally-acquired HIV (CHEU-NPHIV).DESIGN: Longitudinal analysis of anthropometric measurements from a U.S.-based multisite prospective cohort study enrolling...

Cite
Yu W, Jacobson DL, Williams PL, et al. Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV. AIDS. 2021;doi: 10.1097/QAD.0000000000003136.
Yu, W., Jacobson, D. L., Williams, P. L., Patel, K., Geffner, M. E., van Dyke, R. B., Kacanek, D., DiMeglio, L. A., Jao, J. (2021). Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV. AIDS (London, England), . https://doi.org/10.1097/QAD.0000000000003136
Yu, Wendy, et al. "Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV." AIDS (London, England) vol. (2021). doi: https://doi.org/10.1097/QAD.0000000000003136
Yu W, Jacobson DL, Williams PL, Patel K, Geffner ME, van Dyke RB, Kacanek D, DiMeglio LA, Jao J. Growth patterns of uninfected children born to women living with perinatally- versus non-perinatally-acquired HIV. AIDS. 2021 Dec 06; doi: 10.1097/QAD.0000000000003136. Epub 2021 Dec 06. PMID: 34860195.
Copy Download .nbib Format: NLM
Capture-induced transition in foamy suspensions.

Soft matter

Khidas Y, Haffner B, Pitois O.
PMID: 24752206
Soft Matter. 2014 Jun 21;10(23):4137-41. doi: 10.1039/c4sm00246f.

We investigate the drainage behaviour of foamy granular suspensions. Results reveal large fluctuations in the drainage velocity as bubble size, particle size and gas volume fraction are varied for a given particle volume fraction. Particle capture is proved to...

Cite
Khidas Y, Haffner B, Pitois O. Capture-induced transition in foamy suspensions. Soft Matter. 2014;10(23):4137-41doi: 10.1039/c4sm00246f.
Khidas, Y., Haffner, B., & Pitois, O. (2014). Capture-induced transition in foamy suspensions. Soft matter, 10(23), 4137-41. https://doi.org/10.1039/c4sm00246f
Khidas, Y, et al. "Capture-induced transition in foamy suspensions." Soft matter vol. 10,23 (2014): 4137-41. doi: https://doi.org/10.1039/c4sm00246f
Khidas Y, Haffner B, Pitois O. Capture-induced transition in foamy suspensions. Soft Matter. 2014 Jun 21;10(23):4137-41. doi: 10.1039/c4sm00246f. PMID: 24752206.
Copy Download .nbib Format: NLM
Diurnal metabolic control in cyanobacteria requires perception of second messenger signaling molecule c-di-AMP by the carbon control protein SbtB.

Science advances

Selim KA, Haffner M, Burkhardt M, Mantovani O, Neumann N, Albrecht R, Seifert R, Krüger L, Stülke J, Hartmann MD, Hagemann M, Forchhammer K.
PMID: 34878830
Sci Adv. 2021 Dec 10;7(50):eabk0568. doi: 10.1126/sciadv.abk0568. Epub 2021 Dec 08.

[Figure: see text].

Cite
Selim KA, Haffner M, Burkhardt M, et al. Diurnal metabolic control in cyanobacteria requires perception of second messenger signaling molecule c-di-AMP by the carbon control protein SbtB. Sci Adv. 2021;7(50):eabk0568doi: 10.1126/sciadv.abk0568.
Selim, K. A., Haffner, M., Burkhardt, M., Mantovani, O., Neumann, N., Albrecht, R., Seifert, R., Krüger, L., Stülke, J., Hartmann, M. D., Hagemann, M., & Forchhammer, K. (2021). Diurnal metabolic control in cyanobacteria requires perception of second messenger signaling molecule c-di-AMP by the carbon control protein SbtB. Science advances, 7(50), eabk0568. https://doi.org/10.1126/sciadv.abk0568
Selim, Khaled A, et al. "Diurnal metabolic control in cyanobacteria requires perception of second messenger signaling molecule c-di-AMP by the carbon control protein SbtB." Science advances vol. 7,50 (2021): eabk0568. doi: https://doi.org/10.1126/sciadv.abk0568
Selim KA, Haffner M, Burkhardt M, Mantovani O, Neumann N, Albrecht R, Seifert R, Krüger L, Stülke J, Hartmann MD, Hagemann M, Forchhammer K. Diurnal metabolic control in cyanobacteria requires perception of second messenger signaling molecule c-di-AMP by the carbon control protein SbtB. Sci Adv. 2021 Dec 10;7(50):eabk0568. doi: 10.1126/sciadv.abk0568. Epub 2021 Dec 08. PMID: 34878830.
Copy Download .nbib Format: NLM
Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected.

Journal of neurovirology

Shiau S, Yu W, Jacobson DL, Nichols S, McFarland EJ, Chen JS, Dirajlal-Fargo S, Surowiec K, Geffner ME, Jao J.
PMID: 34524627
J Neurovirol. 2021 Oct;27(5):702-715. doi: 10.1007/s13365-021-01005-8. Epub 2021 Sep 15.

We investigated the association of metabolic syndrome (MetS) and its components [abdominal obesity, elevated triglycerides (TG), low HDL cholesterol, elevated blood pressure (BP), and impaired fasting glycemia (IFG)] with neurocognitive impairment in youth with perinatally acquired HIV (YPHIV) or...

Cite
Shiau S, Yu W, Jacobson DL, et al. Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected. J Neurovirol. 2021;27(5):702-715doi: 10.1007/s13365-021-01005-8.
Shiau, S., Yu, W., Jacobson, D. L., Nichols, S., McFarland, E. J., Chen, J. S., Dirajlal-Fargo, S., Surowiec, K., Geffner, M. E., Jao, J. (2021). Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected. Journal of neurovirology, 27(5), 702-715. https://doi.org/10.1007/s13365-021-01005-8
Shiau, Stephanie, et al. "Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected." Journal of neurovirology vol. 27,5 (2021): 702-715. doi: https://doi.org/10.1007/s13365-021-01005-8
Shiau S, Yu W, Jacobson DL, Nichols S, McFarland EJ, Chen JS, Dirajlal-Fargo S, Surowiec K, Geffner ME, Jao J. Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected. J Neurovirol. 2021 Oct;27(5):702-715. doi: 10.1007/s13365-021-01005-8. Epub 2021 Sep 15. PMID: 34524627.
Copy Download .nbib Format: NLM
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

bioRxiv : the preprint server for biology

Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, VanBlargan LA, De Marco A, Zepeda SK, Iulio JD, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà P, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Veesler D, Snell G, Corti D.
PMID: 34931194
bioRxiv. 2021 Dec 20; doi: 10.1101/2021.12.12.472269.

The recently emerged SARS-CoV-2 Omicron variant harbors 37 amino acid substitutions in the spike (S) protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody therapeutics. Here, we...

Cite
Cameroni E, Saliba C, Bowen JE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021;doi: 10.1101/2021.12.12.472269.
Cameroni, E., Saliba, C., Bowen, J. E., Rosen, L. E., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., Zepeda, S. K., Iulio, J. D., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Veesler, D., Snell, G., & Corti, D. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv : the preprint server for biology, . https://doi.org/10.1101/2021.12.12.472269
Cameroni, Elisabetta, et al. "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift." bioRxiv : the preprint server for biology vol. (2021). doi: https://doi.org/10.1101/2021.12.12.472269
Cameroni E, Saliba C, Bowen JE, Rosen LE, Culap K, Pinto D, VanBlargan LA, De Marco A, Zepeda SK, Iulio JD, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà P, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Veesler D, Snell G, Corti D. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. bioRxiv. 2021 Dec 20; doi: 10.1101/2021.12.12.472269. PMID: 34931194; PMCID: PMC8687478.
Copy Download .nbib Format: NLM
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.

Nature

Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D.
PMID: 35016195
Nature. 2021 Dec 23; doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23.

The recently emerged SARS-CoV-2 Omicron variant encodes 37 amino acid substitutions in the spike (S) protein, 15 of which are in the receptor-binding domain (RBD), thereby raising concerns about the effectiveness of available vaccines and antibody therapeutics. Here, we...

Cite
Cameroni E, Bowen JE, Rosen LE, et al. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021;doi: 10.1038/s41586-021-04386-2.
Cameroni, E., Bowen, J. E., Rosen, L. E., Saliba, C., Zepeda, S. K., Culap, K., Pinto, D., VanBlargan, L. A., De Marco, A., di Iulio, J., Zatta, F., Kaiser, H., Noack, J., Farhat, N., Czudnochowski, N., Havenar-Daughton, C., Sprouse, K. R., Dillen, J. R., Powell, A. E., Chen, A., Maher, C., Yin, L., Sun, D., Soriaga, L., Bassi, J., Silacci-Fregni, C., Gustafsson, C., Franko, N. M., Logue, J., Iqbal, N. T., Mazzitelli, I., Geffner, J., Grifantini, R., Chu, H., Gori, A., Riva, A., Giannini, O., Ceschi, A., Ferrari, P., Cippà, P. E., Franzetti-Pellanda, A., Garzoni, C., Halfmann, P. J., Kawaoka, Y., Hebner, C., Purcell, L. A., Piccoli, L., Pizzuto, M. S., Walls, A. C., Diamond, M. S., Telenti, A., Virgin, H. W., Lanzavecchia, A., Snell, G., Veesler, D., & Corti, D. (2021). Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature, . https://doi.org/10.1038/s41586-021-04386-2
Cameroni, Elisabetta, et al. "Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift." Nature vol. (2021). doi: https://doi.org/10.1038/s41586-021-04386-2
Cameroni E, Bowen JE, Rosen LE, Saliba C, Zepeda SK, Culap K, Pinto D, VanBlargan LA, De Marco A, di Iulio J, Zatta F, Kaiser H, Noack J, Farhat N, Czudnochowski N, Havenar-Daughton C, Sprouse KR, Dillen JR, Powell AE, Chen A, Maher C, Yin L, Sun D, Soriaga L, Bassi J, Silacci-Fregni C, Gustafsson C, Franko NM, Logue J, Iqbal NT, Mazzitelli I, Geffner J, Grifantini R, Chu H, Gori A, Riva A, Giannini O, Ceschi A, Ferrari P, Cippà PE, Franzetti-Pellanda A, Garzoni C, Halfmann PJ, Kawaoka Y, Hebner C, Purcell LA, Piccoli L, Pizzuto MS, Walls AC, Diamond MS, Telenti A, Virgin HW, Lanzavecchia A, Snell G, Veesler D, Corti D. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2021 Dec 23; doi: 10.1038/s41586-021-04386-2. Epub 2021 Dec 23. PMID: 35016195.
Copy Download .nbib Format: NLM
Showing 277 to 282 of 282 entries